Identification of hepatitis B virus core mutants by PCR-RFLP in chronic hepatitis B patients from Punjab, Pakistan

M A Aslam1, F R Awan, I Tauseef

  • 1Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan. m_asad_aslam786@yahoo.com

Archives of Virology
|November 22, 2007
PubMed

Insights

Hepatitis B virus (HBV) core gene variations were studied in Pakistani chronic infection patients. Unique mutations were identified, potentially explaining disease chronicity and aiding targeted vaccine development for this population.

Area of Science:

  • Virology
  • Genetics
  • Public Health

Background:

  • Chronic hepatitis B virus (HBV) infection is a global health concern.
  • Core gene variations are implicated in the development of chronic HBV infection.

Purpose of the Study:

  • To identify variations in the HBV core gene region within a Pakistani chronic hepatitis B patient cohort.
  • To investigate potential links between core gene mutations and HBV chronicity in this population.

Main Methods:

  • PCR-based restriction fragment length polymorphism (PCR-RFLP) was employed.
  • Ava II and Msp I restriction enzymes were used for core region genotyping.
  • HBV DNA was detected in 50 out of 57 chronic hepatitis B patients.

Main Results:

  • The most common mutation patterns observed were at nucleotide (nt) 2147 and nt 2362 for Ava II (A4 type, 74%) and nt 2331 for Msp I (M1 type, 66%).
  • These genotypic patterns appear unique to the Pakistani population, differing from previous studies.
  • Specific mutations were identified in the HBV core gene of Pakistani patients.

Conclusions:

  • The identified HBV core gene variations are unique to the Pakistani population.
  • These variations may contribute to the chronicity of HBV infection in Pakistan.
  • Characterization of these core mutants could inform the development of population-specific vaccines.